Show simple item record

dc.contributor.authorBagir, Gulay Simsek
dc.contributor.authorErtorer, Melek Eda
dc.date.accessioned2019-06-11T12:53:26Z
dc.date.available2019-06-11T12:53:26Z
dc.date.issued2017
dc.identifier.issn1301-2193
dc.identifier.urihttp://www.turkjem.org/uploads/pdf/438749850268192.pdf
dc.identifier.urihttp://hdl.handle.net/11727/3455
dc.description.abstractHyperglycemia is a well-recognized risk factor for hospital-related complications, prolonged stay in the hospital and even mortality. The patients with in-hospital hyperglycemia may be categorized into three groups: i) Patients who have been diagnosed as having diabetes mellitus (DM) before admission; ii) Patients with newly diagnosed DM; and iii) Patients with stress hyperglycemia. The release of stress hormones, such as cortisol, catecholamines, glucagon, growth hormone and the related acceleration in gluconeogenesis and glycogenolysis, medications used for the treatment of primary diseases, such as glucocorticoids and vasopressors, are all claimed to be responsible for the development of in-hospital hyperglycemia. Glucose normalization with insulin therapy has been demonstrated to significantly decrease the morbidity and mortality in all the three groups. Therefore, it is recommended to monitor blood glucose levels for all hospitalized patients irrespective of the accompanying DM diagnosis.en_US
dc.language.isoengen_US
dc.relation.isversionof10.25179/tiem.2017-56535en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHyperglycemiaen_US
dc.subjectHospitalen_US
dc.subjectStressen_US
dc.titleHyperglycemia in Hospital: Diagnosis, Classification, Clinical Implications and Treatmenten_US
dc.typereviewen_US
dc.relation.journalTURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISMen_US
dc.identifier.volume21en_US
dc.identifier.issue2en_US
dc.identifier.startpage47en_US
dc.identifier.endpage51en_US
dc.identifier.wos000406492400005


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record